$NHI
NATIONAL HEALTH INVESTORS INC

2022 Q1 Form 10-Q Financial Statement

#000087786022000041 Filed on May 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1 2021
Revenue $71.33M $80.89M $298.7M
YoY Change -11.82% -2.64% -10.24%
Cost Of Revenue $3.038M $2.160M $11.64M
YoY Change 40.65% 39.35% 19.98%
Gross Profit $68.29M $78.72M $287.1M
YoY Change -13.25% -3.47% -11.18%
Gross Profit Margin 95.74% 97.32% 96.1%
Selling, General & Admin $10.17M $8.350M $20.13M
YoY Change 21.82% 70.76% 33.29%
% of Gross Profit 14.9% 10.61% 7.01%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $18.27M $20.81M $80.80M
YoY Change -12.18% 1.78% -2.83%
% of Gross Profit 26.76% 26.43% 28.15%
Operating Expenses $66.21M $44.24M $216.1M
YoY Change 49.65% 3.91% 33.61%
Operating Profit $2.081M $34.48M $70.94M
YoY Change -93.96% -11.53% -56.06%
Interest Expense $10.20M $12.97M $50.81M
YoY Change -21.39% -8.25% -3.92%
% of Operating Profit 490.05% 37.63% 71.63%
Other Income/Expense, Net $350.0K
YoY Change
Pretax Income $8.246M $35.38M $112.0M
YoY Change -76.69% -42.06% -39.58%
Income Tax
% Of Pretax Income
Net Earnings $8.399M $35.33M $111.8M
YoY Change -76.23% -42.1% -39.61%
Net Earnings / Revenue 11.78% 43.68% 37.43%
Basic Earnings Per Share $0.18 $0.78 $2.45
Diluted Earnings Per Share $0.18 $0.78 $2.44
COMMON SHARES
Basic Shares Outstanding 45.85M shares 45.31M shares 45.71M shares
Diluted Shares Outstanding 45.85M shares 45.36M shares 45.73M shares

Balance Sheet

Concept 2022 Q1 2021 Q1 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $36.12M $113.4M $37.41M
YoY Change -68.15% 146.52% -13.6%
Cash & Equivalents $36.12M $113.4M $37.41M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $3.210M
Other Receivables $96.20M
Total Short-Term Assets $130.9M $211.8M $136.8M
YoY Change -38.22% 56.54% -3.38%
LONG-TERM ASSETS
Property, Plant & Equipment $2.201B $2.648B $2.318B
YoY Change -16.88% -1.68% -13.1%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $5.000M $3.300M
YoY Change 51.52% 662.12%
Other Assets $135.8M $2.900M $68.47M
YoY Change 4582.59% -91.42% 2182.37%
Total Long-Term Assets $2.672B $2.971B $2.702B
YoY Change -10.09% -2.01% -9.29%
TOTAL ASSETS
Total Short-Term Assets $130.9M $211.8M $136.8M
Total Long-Term Assets $2.672B $2.971B $2.702B
Total Assets $2.803B $3.183B $2.839B
YoY Change -11.96% 0.49% -9.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $19.11M $23.70M $23.18M
YoY Change -19.36% -31.7% -8.01%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $60.38M $84.90M $73.29M
YoY Change -28.88% -10.25% -14.49%
LONG-TERM LIABILITIES
Long-Term Debt $1.249B $1.525B $1.243B
YoY Change -18.08% -1.56% -17.1%
Other Long-Term Liabilities $4.285M $11.00M $5.725M
YoY Change -61.05% -36.78% -54.56%
Total Long-Term Liabilities $1.253B $1.536B $1.249B
YoY Change -18.39% -1.95% -17.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $60.38M $84.90M $73.29M
Total Long-Term Liabilities $1.253B $1.536B $1.249B
Total Liabilities $1.314B $1.621B $1.332B
YoY Change -18.93% -2.43% -17.19%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $1.597B $1.595B
YoY Change 0.12% 5.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.479B $1.552B $1.507B
YoY Change
Total Liabilities & Shareholders Equity $2.803B $3.183B $2.839B
YoY Change -11.96% 0.49% -9.02%

Cashflow Statement

Concept 2022 Q1 2021 Q1 2021
OPERATING ACTIVITIES
Net Income $8.399M $35.33M $111.8M
YoY Change -76.23% -42.1% -39.61%
Depreciation, Depletion And Amortization $18.27M $20.81M $80.80M
YoY Change -12.18% 1.78% -2.83%
Cash From Operating Activities $38.68M $56.91M $210.9M
YoY Change -32.04% -0.3% -9.17%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $50.35M
YoY Change -100.0% -56.87%
Acquisitions
YoY Change
Other Investing Activities -$2.060M -$9.100M $232.1M
YoY Change -77.36% -131.06% 1685.34%
Cash From Investing Activities -$2.060M -$9.133M $185.3M
YoY Change -77.44% -82.1% -306.52%
FINANCING ACTIVITIES
Cash Dividend Paid $41.27M $49.82M $182.9M
YoY Change -17.17% 6.41% -6.0%
Common Stock Issuance & Retirement, Net $0.00 $47.95M $47.90M
YoY Change -100.0% -55216.09% 38.44%
Debt Paid & Issued, Net $75.10M $100.1M $293.3M
YoY Change -24.97% 32825.66% 570.76%
Cash From Financing Activities -$36.18M $22.11M -$403.0M
YoY Change -263.65% -61.94% 260.58%
NET CHANGE
Cash From Operating Activities $38.68M $56.91M $210.9M
Cash From Investing Activities -$2.060M -$9.133M $185.3M
Cash From Financing Activities -$36.18M $22.11M -$403.0M
Net Change In Cash $443.0K $69.89M -$6.858M
YoY Change -99.37% 8.94% -122.36%
FREE CASH FLOW
Cash From Operating Activities $38.68M $56.91M $210.9M
Capital Expenditures $0.00 $0.00 $50.35M
Free Cash Flow $38.68M $56.91M $160.5M
YoY Change -32.04% -58.57% 39.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000877860
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45850868 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45850599 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45850868 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45850599 shares
CY2021 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.9000
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.90
CY2020 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.1025
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.1025
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-10822
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
National Health Investors Inc
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
62-1470956
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
222 Robert Rose Drive
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Murfreesboro
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37129
CY2022Q1 dei City Area Code
CityAreaCode
(615)
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
890-9100
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2022Q1 dei Trading Symbol
TradingSymbol
NHI
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
45851044 shares
CY2022Q1 us-gaap Land
Land
180503000 USD
CY2021Q4 us-gaap Land
Land
186658000 USD
CY2022Q1 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
2601905000 USD
CY2021Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
2707422000 USD
CY2022Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
851000 USD
CY2021Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
468000 USD
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2783259000 USD
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2894548000 USD
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
582175000 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
576668000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2201084000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2317880000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5134000 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5210000 USD
CY2022Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
316390000 USD
CY2021Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
299952000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36121000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37412000 USD
CY2022Q1 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
94739000 USD
CY2021Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
96198000 USD
CY2022Q1 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
131988000 USD
CY2021Q4 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
66398000 USD
CY2022Q1 us-gaap Other Assets
OtherAssets
22181000 USD
CY2021Q4 us-gaap Other Assets
OtherAssets
21036000 USD
CY2022Q1 us-gaap Assets
Assets
2802503000 USD
CY2021Q4 us-gaap Assets
Assets
2838876000 USD
CY2022Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1249044000 USD
CY2021Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1242883000 USD
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
19112000 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
23181000 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
41265000 USD
CY2021Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
41266000 USD
CY2022Q1 us-gaap Security Deposit Liability
SecurityDepositLiability
0 USD
CY2021Q4 us-gaap Security Deposit Liability
SecurityDepositLiability
8838000 USD
CY2022Q1 us-gaap Deferred Revenue
DeferredRevenue
4285000 USD
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
5725000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
1313706000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
1321893000 USD
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
459000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
459000 USD
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1596258000 USD
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1591182000 USD
CY2022Q1 us-gaap Cumulative Earnings Deficit
CumulativeEarningsDeficit
-117424000 USD
CY2021Q4 us-gaap Cumulative Earnings Deficit
CumulativeEarningsDeficit
-84558000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1479293000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1507083000 USD
CY2022Q1 us-gaap Minority Interest
MinorityInterest
9504000 USD
CY2021Q4 us-gaap Minority Interest
MinorityInterest
9900000 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1488797000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1516983000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2802503000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2838876000 USD
CY2022Q1 us-gaap Lease Income
LeaseIncome
64559000 USD
CY2021Q1 us-gaap Lease Income
LeaseIncome
74749000 USD
CY2022Q1 us-gaap Interest Income Operating
InterestIncomeOperating
6768000 USD
CY2021Q1 us-gaap Interest Income Operating
InterestIncomeOperating
6136000 USD
CY2022Q1 us-gaap Revenues
Revenues
71327000 USD
CY2021Q1 us-gaap Revenues
Revenues
80885000 USD
CY2022Q1 us-gaap Depreciation
Depreciation
18272000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
20806000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
10198000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
12973000 USD
CY2022Q1 us-gaap Legal Fees
LegalFees
1827000 USD
CY2021Q1 us-gaap Legal Fees
LegalFees
130000 USD
CY2022Q1 nhi Franchise Excise And Other Taxes
FranchiseExciseAndOtherTaxes
244000 USD
CY2021Q1 nhi Franchise Excise And Other Taxes
FranchiseExciseAndOtherTaxes
233000 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8101000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7989000 USD
CY2022Q1 nhi Lessor Property Costs Paid From Tenant Escrow
LessorPropertyCostsPaidFromTenantEscrow
3038000 USD
CY2021Q1 nhi Lessor Property Costs Paid From Tenant Escrow
LessorPropertyCostsPaidFromTenantEscrow
2161000 USD
CY2022Q1 nhi Loanand Lease Lossesand Recoveries Net
LoanandLeaseLossesandRecoveriesNet
24528000 USD
CY2021Q1 nhi Loanand Lease Lossesand Recoveries Net
LoanandLeaseLossesandRecoveriesNet
-50000 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
66208000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
44242000 USD
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
297000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-808000 USD
CY2022Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
2981000 USD
CY2021Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0 USD
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-151000 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-451000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
8246000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
35384000 USD
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-153000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
52000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
8399000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
35332000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45850686 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45305087 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45851061 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45357773 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.78
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.78
CY2022Q1 us-gaap Profit Loss
ProfitLoss
8246000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
35384000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
0 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-6000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
0 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-1778000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1772000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
8246000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
37156000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-153000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
52000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8399000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
37104000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
8246000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
35384000 USD
CY2022Q1 us-gaap Depreciation
Depreciation
18272000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
20806000 USD
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1087000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1192000 USD
CY2022Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
120000 USD
CY2021Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
131000 USD
CY2022Q1 nhi Amortization Of Lease Inducements
AmortizationOfLeaseInducements
252000 USD
CY2021Q1 nhi Amortization Of Lease Inducements
AmortizationOfLeaseInducements
260000 USD
CY2022Q1 us-gaap Straight Line Rent
StraightLineRent
1079000 USD
CY2021Q1 us-gaap Straight Line Rent
StraightLineRent
4241000 USD
CY2022Q1 us-gaap Other Noncash Income
OtherNoncashIncome
880000 USD
CY2021Q1 us-gaap Other Noncash Income
OtherNoncashIncome
700000 USD
CY2022Q1 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
-8838000 USD
CY2021Q1 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
0 USD
CY2022Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
2981000 USD
CY2021Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0 USD
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
297000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-808000 USD
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-151000 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-451000 USD
CY2022Q1 nhi Loanand Lease Lossesand Recoveries Net
LoanandLeaseLossesandRecoveriesNet
24528000 USD
CY2021Q1 nhi Loanand Lease Lossesand Recoveries Net
LoanandLeaseLossesandRecoveriesNet
-50000 USD
CY2022Q1 nhi Paymentof Tenant Lease Incentives
PaymentofTenantLeaseIncentives
0 USD
CY2021Q1 nhi Paymentof Tenant Lease Incentives
PaymentofTenantLeaseIncentives
-1042000 USD
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5083000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5446000 USD
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
107000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
484000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4252000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-735000 USD
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-385000 USD
CY2021Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-52000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
38680000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
56912000 USD
CY2022Q1 us-gaap Payments To Acquire Mortgage Notes Receivable
PaymentsToAcquireMortgageNotesReceivable
16350000 USD
CY2021Q1 us-gaap Payments To Acquire Mortgage Notes Receivable
PaymentsToAcquireMortgageNotesReceivable
8412000 USD
CY2022Q1 us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
988000 USD
CY2021Q1 us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
442000 USD
CY2022Q1 us-gaap Proceeds From Sale Of Wholly Owned Real Estate And Real Estate Acquired In Settlement Of Loans
ProceedsFromSaleOfWhollyOwnedRealEstateAndRealEstateAcquiredInSettlementOfLoans
13170000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Wholly Owned Real Estate And Real Estate Acquired In Settlement Of Loans
ProceedsFromSaleOfWhollyOwnedRealEstateAndRealEstateAcquiredInSettlementOfLoans
0 USD
CY2022Q1 nhi Payments To Renovate Real Estate
PaymentsToRenovateRealEstate
165000 USD
CY2021Q1 nhi Payments To Renovate Real Estate
PaymentsToRenovateRealEstate
1443000 USD
CY2022Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
0 USD
CY2021Q1 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
8000 USD
CY2022Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
297000 USD
CY2021Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
288000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2060000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9133000 USD
CY2022Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
85000000 USD
CY2021Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
30000000 USD
CY2022Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
CY2021Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
298000000 USD
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
75098000 USD
CY2021Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
100094000 USD
CY2022Q1 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
396784000 USD
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4535000 USD
CY2021Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4459000 USD
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
47951000 USD
CY2022Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
271000 USD
CY2021Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
258000 USD
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
41266000 USD
CY2021Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
49818000 USD
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7000 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-36177000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22106000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
443000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
69885000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39485000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46343000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39928000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
116228000 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
12920000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
9674000 USD
CY2022Q1 us-gaap Noncash Or Part Noncash Acquisition Other Assets Acquired1
NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1
33000 USD
CY2021Q1 us-gaap Noncash Or Part Noncash Acquisition Other Assets Acquired1
NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1
0 USD
CY2022Q1 nhi Changein Accounts Payable Investmentsin Real Estate Construction
ChangeinAccountsPayableInvestmentsinRealEstateConstruction
0 USD
CY2021Q1 nhi Changein Accounts Payable Investmentsin Real Estate Construction
ChangeinAccountsPayableInvestmentsinRealEstateConstruction
-112000 USD
CY2022Q1 nhi Change In Accounts Payable Renovations Of Existing Real Estate
ChangeInAccountsPayableRenovationsOfExistingRealEstate
-219000 USD
CY2021Q1 nhi Change In Accounts Payable Renovations Of Existing Real Estate
ChangeInAccountsPayableRenovationsOfExistingRealEstate
0 USD
CY2022Q1 nhi Change In Accounts Payable Related To Distributions To Noncontrolling Interests
ChangeInAccountsPayableRelatedToDistributionsToNoncontrollingInterests
-28000 USD
CY2021Q1 nhi Change In Accounts Payable Related To Distributions To Noncontrolling Interests
ChangeInAccountsPayableRelatedToDistributionsToNoncontrollingInterests
-25000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1516983000 USD
CY2021 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
243000 USD
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
8246000 USD
CY2021Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
7000 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
5083000 USD
CY2021 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
41265000 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1488797000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1522945000 USD
CY2020 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
37156000 USD
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
47951000 USD
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
5446000 USD
CY2020 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
50550000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1562715000 USD
CY2022Q1 nhi Real Estate Investment Property Portfolio Assets
RealEstateInvestmentPropertyPortfolioAssets
2800000000 USD
CY2022Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
186 numberOfProperty
CY2022Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
32 numberOfStates
CY2022Q1 nhi Number Of Lessees
NumberOfLessees
27 lessee
CY2022Q1 nhi Number Of Health Care Properties Related To Mortgage Notes Receivables
NumberOfHealthCarePropertiesRelatedToMortgageNotesReceivables
15 numberOfBedOrUnitInTheProperty
CY2022Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
321500000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5100000 USD
CY2022Q1 nhi Variable Interest Entity Number Of Entities Not Primary Beneficiary
VariableInterestEntityNumberOfEntitiesNotPrimaryBeneficiary
10 numberOfProperty
CY2022Q1 us-gaap Cash
Cash
36121000 USD
CY2021Q1 us-gaap Cash
Cash
113375000 USD
CY2022Q1 us-gaap Restricted Cash
RestrictedCash
3807000 USD
CY2021Q1 us-gaap Restricted Cash
RestrictedCash
2853000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39928000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
116228000 USD
CY2022Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
24600000 USD
CY2022Q1 us-gaap Revenue Recognition Leases
RevenueRecognitionLeases
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rental Income</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leases generally provide for rent escalators throughout the term of the lease. Base rental income is recognized using the straight-line method over the term of the lease to the extent that lease payments are considered collectible and the lease provides for specific contractual escalators. The Company reviews its operating lease receivables for collectibility on a regular basis, taking into consideration changes in factors such as the tenant’s payment history, the financial condition of the tenant, business conditions in which the tenant operates and economic conditions in the area where the property is located. In the event that collectibility with respect to any tenant is not probable, a direct write-off of the receivable is made as an adjustment to rental income and any future rental revenue is recognized only when the tenant makes a rental payment.</span></div>
CY2022Q1 us-gaap Proceeds From Sale Of Wholly Owned Real Estate And Real Estate Acquired In Settlement Of Loans
ProceedsFromSaleOfWhollyOwnedRealEstateAndRealEstateAcquiredInSettlementOfLoans
13170000 USD
CY2022Q1 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
132000000 USD
CY2022Q1 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
24600000 USD
CY2022Q1 nhi Nonportfolio Assets Original Cost
NonportfolioAssetsOriginalCost
2600000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5100000 USD
CY2022Q1 us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
2986133000 USD
CY2022Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
321524000 USD
CY2022Q1 us-gaap Revenues
Revenues
71327000 USD
CY2021Q1 us-gaap Revenues
Revenues
80885000 USD
CY2022Q1 nhi Number Of Joint Ventures
NumberOfJointVentures
2 numberOfJointVentures
CY2022Q1 nhi Minimum Holding Period After Purchase Option Exercise
MinimumHoldingPeriodAfterPurchaseOptionExercise
P1Y
CY2022Q1 nhi Number Of Health Care Properties Related To Mortgage Notes Receivables
NumberOfHealthCarePropertiesRelatedToMortgageNotesReceivables
15 numberOfProperty
CY2022Q1 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
202424000 USD
CY2022Q1 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
264680000 USD
CY2022Q1 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
262476000 USD
CY2022Q1 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
264729000 USD
CY2022Q1 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
268834000 USD
CY2022Q1 us-gaap Lessor Operating Lease Payments To Be Received Five Years
LessorOperatingLeasePaymentsToBeReceivedFiveYears
232226000 USD
CY2022Q1 us-gaap Lessor Operating Lease Payments To Be Received Thereafter
LessorOperatingLeasePaymentsToBeReceivedThereafter
988105000 USD
CY2022Q1 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
2483474000 USD
CY2022Q1 us-gaap Lease Income
LeaseIncome
64559000 USD
CY2021Q1 us-gaap Lease Income
LeaseIncome
74749000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5100000 USD
CY2022Q1 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
108 numberOfBedOrUnitInTheProperty
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5134000 USD
CY2022Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
316390000 USD
CY2022Q1 nhi Probability Of Default Increase Current Conditions Adjustment
ProbabilityOfDefaultIncreaseCurrentConditionsAdjustment
0.20
CY2022Q1 nhi Probability Of Default Increase Current Conditions Adjustment
ProbabilityOfDefaultIncreaseCurrentConditionsAdjustment
0.20
CY2022Q1 nhi Estimated Credit Losses Current Conditions Adjustment Combined
EstimatedCreditLossesCurrentConditionsAdjustmentCombined
0.44
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5210000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
-76000 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5134000 USD
CY2022Q1 us-gaap Equity Method Investments
EquityMethodInvestments
5000000 USD
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
300000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-800000 USD
CY2022Q1 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
15200000 USD
CY2022Q1 us-gaap Line Of Credit
LineOfCredit
85000000 USD
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2022Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
10055000 USD
CY2021Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
6234000 USD
CY2022Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1249044000 USD
CY2021Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1242883000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
291000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths
475408000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
75425000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
125816000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour
85000000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive
100000000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive
400000000 USD
CY2022Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1261940000 USD
CY2022Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
2841000 USD
CY2022Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
10055000 USD
CY2022Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1249044000 USD
CY2022Q1 us-gaap Line Of Credit Facility Unused Capacity Commitment Fee Percentage
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
0.0025
CY2022Q1 nhi Debt Instrument Variable Rate Basis Minimum
DebtInstrumentVariableRateBasisMinimum
41
CY2022Q1 us-gaap Unsecured Debt
UnsecuredDebt
400000000 USD
CY2022Q1 nhi Debt Leverage Limit Coupon Change Trigger
DebtLeverageLimitCouponChangeTrigger
0.50
CY2022Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
9558000 USD
CY2021Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
10452000 USD
CY2022Q1 us-gaap Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion
DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
0 USD
CY2021Q1 us-gaap Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion
DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
1778000 USD
CY2022Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
2000 USD
CY2021Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
16000 USD
CY2022Q1 nhi Amortization Of Financing Costs Exclusive Of Amounts Written Off
AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff
642000 USD
CY2021Q1 nhi Amortization Of Financing Costs Exclusive Of Amounts Written Off
AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff
759000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
10198000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
12973000 USD
CY2022Q1 us-gaap Loans And Leases Receivable Commitments Fixed Rates
LoansAndLeasesReceivableCommitmentsFixedRates
274500000 USD
CY2022Q1 nhi Maximum Commitment For All Active Development Projects
MaximumCommitmentForAllActiveDevelopmentProjects
31300000 USD
CY2022Q1 us-gaap Development In Process
DevelopmentInProcess
23900000 USD
CY2022Q1 nhi Contingent Funding Commitment Amount Funded
ContingentFundingCommitmentAmountFunded
1000000 USD
CY2022Q1 nhi Contingent Funding Commitment
ContingentFundingCommitment
33900000 USD
CY2022Q1 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
0 USD
CY2022Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
955000 USD
CY2022Q1 us-gaap Litigation Settlement Amount Awarded From Other Party
LitigationSettlementAmountAwardedFromOtherParty
6900000 USD
CY2022Q1 nhi Number Of Joint Ventures
NumberOfJointVentures
2 numberOfJointVentures
CY2022Q1 us-gaap Litigation Settlement Amount Awarded From Other Party
LitigationSettlementAmountAwardedFromOtherParty
6900000 USD
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5083000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5446000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.81
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
14.54
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.071
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.067
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.492
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.481
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y10M24D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y10M24D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0172
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0033
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1033838 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
83.54
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
652000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
69.20
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
20000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
60.52
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1665838 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
78.20
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1180824 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
79.31
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1652505 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
78.10
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
53.41
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
7500 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
53.41
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
23000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
62.33
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
74498 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
77.93
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2240507 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
70.71
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y6M25D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1719487 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
74.34
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y3M7D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3800000 USD
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1900000 USD
CY2022Q1 nhi Aggregate Intrinsic Value Per Share Options Exercised
AggregateIntrinsicValuePerShareOptionsExercised
4.94
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
100000 USD
CY2021Q1 nhi Aggregate Intrinsic Value Per Share Options Exercised
AggregateIntrinsicValuePerShareOptionsExercised
9.27
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
200000 USD
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
4900000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
8399000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
35332000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45850686 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45305087 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
45850686 shares
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
45305087 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
375 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
10873 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
41813 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45851061 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45357773 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.78
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.78
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
481068 shares
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
216762 shares
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.90
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.1025

Files In Submission

Name View Source Status
0000877860-22-000041-index-headers.html Edgar Link pending
0000877860-22-000041-index.html Edgar Link pending
0000877860-22-000041.txt Edgar Link pending
0000877860-22-000041-xbrl.zip Edgar Link pending
amendmentno1totermloanagre.htm Edgar Link pending
creditagreementeffectivema.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_0a.jpg Edgar Link pending
image_0c.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
nhi-20220331.htm Edgar Link pending
nhi-20220331.xsd Edgar Link pending
nhi-20220331_cal.xml Edgar Link unprocessable
nhi-20220331_def.xml Edgar Link unprocessable
nhi-20220331_htm.xml Edgar Link completed
nhi-20220331_lab.xml Edgar Link unprocessable
nhi-20220331_pre.xml Edgar Link unprocessable
nhi-3312022x10kex312.htm Edgar Link pending
nhi-3312022x10qex311.htm Edgar Link pending
nhi-3312022x10qex32.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
secondsupplementalindentur.htm Edgar Link pending
settlementagreementdatedma.htm Edgar Link pending
Show.js Edgar Link pending